Harch_HBOT_LogoHarch_HBOT_LogoHarch_HBOT_LogoHarch_HBOT_Logo
  • About
    • Paul G Harch MD
      • Bio
      • Curriculum Vitae
    • Our Team
    • Our Service
    • Our Process
  • Hyperbaric Oxygen Therapy
    • What is HBOT?
    • What are the benefits?
    • Can HBOT help you?
    • FAQ’s
  • Conditions
    • Alzheimer’s
    • Arthritis
    • Autism
    • Autoimmune Disorders
    • Bell’s Palsy 
    • Birth Injuries 
    • Burn Injuries 
    • Cerebral Palsy
    • Drowning and Anoxic Brain Injury
    • HBOT for Brain Aneurysm 
    • HBOT of Brain Injury Caused by Substance Abuse 
    • Herpes of the Brain
    • Migraine Headache
    • Mild Cognitive Impairment (MCI) and Dementia
    • Multiple Sclerosis
    • Plastic-Cosmetic Surgery
    • Recovery from Surgery
    • Sports Injuries and Sports Performance/Recovery
    • Stroke
    • Traumatic Brain Injury
  • The Science
    • Published Research
    • Case Studies
    • Lectures
    • Interviews
    • Hyperbaric Therapy and Hyperbaric Oxygen Therapy: New Scientific Definitions
    • SPECT Imaging
      • What is SPECT?
      • SPECT Case Study PDFs
    • SPECT Case Study PDFs
      • The Book
      • The Oxygen Revolution Third Edition Links
  • Press
    • Latest News
    • Media
    • Current Events
    • Testimonials
  • Contact
✕
  • Home
  • The Science Behind HBOT
  • News
  • HOTFAST: Hyperbaric Oxygen Therapy for Acute Stroke
Brain damage HBOT
Chad Rovira – Severe Traumatic Brain Injury Study
February 4, 2009
DCI Harch HBOT figure 6
Study Reaffirms Effectiveness of HBOT in Cerebral Palsy
February 10, 2009
Published by Harch HBOT on February 9, 2009
Categories
  • News
  • Publications
  • Stroke Treatment
Tags
Harch HBOT SPECT 18-7b

Figure 18.7B. Frontal projection three dimensional surface reconstruction of Figure 18.7 A.

HOTFAST: Hyperbaric Oxygen Therapy for Acute Stroke

[stm_post_details]

Soon, the first phase of HOTFAST, a study of Hyperbaric Oxygen Therapy for Acute Stroke, will begin. Dr. James F. Toole, Director of the National Stroke Research Center, President of the World Federation of Neurology, and chaired professor of neurology at Bowman Gray/Wake Forest University School of Medicine in Winston-Salem, North Carolina, will be co -principal investigator along with the author. Dr. Richard Neubauer is senior honorary consultant and the main initiative behind the origination of the study.

This study will be conducted in three phases. The first phase is a feasibility study that will entail entering a minimum total of 13 patients at all of the participating centers to assess the ‘feasibility of completing the protocol as well as the safety issues involved. It will be an uncontrolled trial. The data from this study will be submitted to the NIH for the second phase, which would be a fully funded, randomized, prospective,
controlled-blinded trial. Should this second phase show positive results, it may stand alone or necessitate the third phase, a much larger multicenter trial.

This process began in February 1997, when Drs. Neubauer and Toole held an organizing meeting for the trial at the American Academy of Neurology meeting in Boston. Approximately 15 physicians, including neurologists, hyperbaric, and emergency physicians convened to plan the process and get the ball rolling. This spawned a $50,000 gift from Edgar Otto of National Healthnet to hold the Graylyn Conference at Bowman Gray in November 1997. We invited 50 internationally respected stroke, neurology, emergency, and hyperbaric specialists to the meeting. After the meeting I was asked to be the national coordinator and principal investigator. Dr. Toole subsequently joined me and we proceeded with Dr. Neubauer to the Cerebral Congress on Vascular Disease, Dementia, and Aging in Washington, D.C., in May 1998, where we held an open symposium on developing a stroke/HBO protocol.

Prior to this meeting, I performed a personal phone survey of 60 of the most prominent and experienced hyperbaric centers in the U.S. to assess interest in this project. The response was overwhelmingly positive. We put together a team of individuals to work on the project, formed executive and working committees, and recruited nationally respected stroke and hyperbaric experts. Since that time, we have developed the final protocol and screened and selected pilot sites. Initially, we desired five pilot sites, but as the project evolved, the number has grown to 14, with a waiting list of interested centers. We just finished the final meeting of the pilot sites in New Orleans on February 11, 2000, at the American Heart Association’s annual Stroke Meeting. In attendance were approximately 20 individuals, including a member of the NIH Stroke Division.

I am now performing the final tweaking of the protocol and consent forms, which will be mailed to the pilot sites to complete applications to their local Institutional Review Boards. The protocol is for acute stroke, less than or equal to 6 hours old, and the patients will run a five-day inpatient protocol. Neurological outcome will be documented, but is somewhat unimportant for this phase since we are trying to demonstrate only feasibility and safety. Patients will present for a three-month follow-up. SPECT brain imaging is a part of the study at institutions that have the capability.

There is one international site in Germany that originally was to be a part of the study, but they have decided on a different protocol / dose and will proceed on their own in parallel to our study. The first phase is closed at this point, but interested parties can possibly participate in the second and/or third phases that will involve 30 or more centers. The mix of hospitals includes university, county, city, and private for- and not-for-profit. The first phase is not funded. Should we be denied funding by the NIH, we will seek funding from alternate sources.

We are sorely in need of administrative funding to help the project along, since Dr. Toole, our coordinators Dr. George and Virginia Howard, and I are and have been working on the study gratis for over three years. If you are aware of any benefactors who are interested in funding a worthy cause in a tax-deductible manner, please have them contact us. For more information, I can be reached at [email protected] Phone: 504-309-4948, or 504-304-5877; Virginia Howard can be reached at the coordination center at the University of Alabama, Birmingham, 205-934-7197; or Dr. Toole at the National Stroke Research Center, 336-716-2338.

SCHEDULE A TREATMENT

CALL
HARCH HBOT

ABOUT DR. HARCH
Share
1
Harch HBOT
Harch HBOT

Related posts

May 1, 2025

Hyperbaric Oxygen Therapy for TBI, PTSD & Depression (HBOT Benefits)


Read more
February 14, 2025

Systematic Review & Dosage of HBOT


Read more
January 22, 2025

Drowned Baby Arthur Comes to Harch Hyperbarics Inc.


Read more

Leave a Reply Cancel reply

You must be logged in to post a comment.

CONTACT INFORMATION

Address:
3409 Division St., Suite 201
Metairie, LA 70002
Phone:
504-309-4948
E-mail:
[email protected]
BUSINESS HOURS:
Monday - Friday: 9:00 am - 4:00 pm
Saturday - Sunday: CLOSED
Connect with us:
   
PWD FRIENDLY:
Harch Hyperbarics in Metairie has comfortable handicap accessible accommodations:
• Handicap parking with ramp • Large elevator
• 2 Large handicap accessible bathrooms • Hoyer lift
• Wide hallways for easy navigation with a stretcher
© 2025 Copyright Harch HBOT. All rights reserved.